User:WikiWorks/Taxon

From BugSigDB

(This is an example result page for if a user queried for the NCBI ID "39948".)

Dialister[edit | edit source]

NCBI ID: 39948 NCBI.png

Lineage[edit | edit source]

kingdom
Bacillati (1783272)Bugsigdb.png
phylum
Bacillota (1239)Bugsigdb.png
class
Negativicutes (909932)Bugsigdb.png
order
Veillonellales (1843489)Bugsigdb.png
family
Veillonellaceae (31977)Bugsigdb.png
genus
Dialister (39948)Bugsigdb.png

Signatures containing this taxon

  1. 16S gut community of the Cameron County Hispanic Cohort/Experiment 1/Signature 1
  2. 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19/Experiment 2/Signature 2
  3. 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19/Experiment 3/Signature 1
  4. 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19/Experiment 3/Signature 2
  5. 16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones/Experiment 1/Signature 2
  6. 16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones/Experiment 2/Signature 2
  7. 16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms/Experiment 1/Signature 2
  8. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?/Experiment 3/Signature 2
  9. A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study/Experiment 2/Signature 2
  10. A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients/Experiment 1/Signature 1
  11. A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease/Experiment 2/Signature 2
  12. A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease/Experiment 3/Signature 2
  13. A metagenomic study of the gut microbiome in Behcet's disease/Experiment 1/Signature 2
  14. A prospective microbiome-wide association study of food sensitization and food allergy in early childhood/Experiment 1/Signature 1
  15. Alteration of faecal microbiota balance related to long-term deep meditation/Experiment 1/Signature 2
  16. Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status/Experiment 1/Signature 2
  17. Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing/Experiment 1/Signature 2
  18. Alteration of the gut microbiota profile in children with autism spectrum disorder in China/Experiment 1/Signature 1
  19. Alterations in gut microbiota and host transcriptome of patients with coronary artery disease/Experiment 1/Signature 1
  20. Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population/Experiment 1/Signature 2
  21. Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population/Experiment 2/Signature 2
  22. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 1/Signature 2
  23. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 2/Signature 2
  24. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 5/Signature 2
  25. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19/Experiment 3/Signature 1
  26. Alterations of fecal bacterial communities in patients with lung cancer/Experiment 1/Signature 2
  27. Alterations of fecal bacterial communities in patients with lung cancer/Experiment 2/Signature 2
  28. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer/Experiment 9/Signature 2
  29. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer/Experiment 10/Signature 2
  30. Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1/Signature 2
  31. Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1/Signature 1
  32. Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4/Signature 2
  33. Altered gut microbiota and microbial biomarkers associated with chronic kidney disease/Experiment 1/Signature 2
  34. Altered Gut Microbiota Composition Associated with Eczema in Infants/Experiment 1/Signature 2
  35. Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1/Signature 2
  36. Altitude-dependent agro-ecologies impact the microbiome diversity of scavenging indigenous chicken in Ethiopia/Experiment 3/Signature 1
  37. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 2/Signature 1
  38. Ascaris suum infection was associated with a worm-independent reduction in microbial diversity and altered metabolic potential in the porcine gut microbiome/Experiment 3/Signature 2
  39. Ascaris suum infection was associated with a worm-independent reduction in microbial diversity and altered metabolic potential in the porcine gut microbiome/Experiment 4/Signature 2
  40. Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor/Experiment 1/Signature 2
  41. Association Between Gut Microbiota and Helicobacter pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer/Experiment 5/Signature 1
  42. Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults/Experiment 1/Signature 1
  43. Association of cigarette smoking with oral bacterial microbiota and cardiometabolic health in Chinese adults/Experiment 2/Signature 1
  44. Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 5/Signature 2
  45. Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition/Experiment 9/Signature 2
  46. Association of the Cervical Microbiota With Pregnancy Outcome in a Subfertile Population Undergoing In Vitro Fertilization: A Case-Control Study/Experiment 1/Signature 2
  47. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort/Experiment 1/Signature 1
  48. Associations between the gut microbiome, inflammation and cardiovascular profiles in people with HIV/Experiment 1/Signature 2
  49. Associations between the gut microbiome, inflammation and cardiovascular profiles in people with HIV/Experiment 4/Signature 1
  50. Associations of alcohol with the human gut microbiome and prospective health outcomes in the FINRISK 2002 cohort/Experiment 2/Signature 3

... further results